News

Diabetes

Kimberly Redmond | Equities.com |

Walmart Inc announced Tuesday it will begin offering private-label insulin this summer at a much lower price than branded versions of the life-saving diabetes drug.

The retailer said it is teaming up with Novo Nordisk A/S to sell an exclusive version of analog insulin through Walmart’s private ReliOn brand as part of a push to expand its health offerings.